U.S. Patent Disclosures
Wednesday, July 20, 2011
NeurogesX Inc., of San Mateo, Calif., received a notice of allowance for a patent, titled "Methods and Compositions for Administration of TRVP1 Agonists." Its claims include method of use, formulation and system claims.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.